I am not surprised that an outbreak of fungal meningitis, purportedly caused by a generic injectable steroid, has occurred in the United States [“Steroid linked to meningitis was sent to 23 states,” news article, Oct. 5]. As an anesthesiologist, I have been dealing with drug shortages for years, particularly of generic sterile injectables.

If this problem isn’t solved, compounding pharmacies will be relied upon more frequently to provide the medications we need. The time for government action to prevent these shortages was yesterday; one hopes that someone will take notice now that serious problems are occurring.

Mollyann G. March, Bethesda